Oxbridge Re (OXBR) Competitors

$1.03 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$1.04 +0.01 (+1.17%)

As of 05/22/2026 07:51 PM Eastern

OXBR vs. HIPO, ZBAO, PRHI, HUIZ, and GOCO

Should you buy Oxbridge Re stock or one of its competitors? MarketBeat compares Oxbridge Re with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oxbridge Re include Hippo (HIPO), Zhibao Technology (ZBAO), Presurance (PRHI), Huize (HUIZ), and GoHealth (GOCO). These companies are all part of the "insurance" industry.

How does Oxbridge Re compare to Hippo?

Hippo (NYSE:HIPO) and Oxbridge Re (NASDAQ:OXBR) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

Hippo currently has a consensus price target of $38.33, indicating a potential upside of 46.44%. Given Hippo's stronger consensus rating and higher probable upside, analysts clearly believe Hippo is more favorable than Oxbridge Re.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Hippo had 11 more articles in the media than Oxbridge Re. MarketBeat recorded 11 mentions for Hippo and 0 mentions for Oxbridge Re. Hippo's average media sentiment score of 0.22 beat Oxbridge Re's score of 0.00 indicating that Hippo is being referred to more favorably in the media.

Company	Overall Sentiment
Hippo	Neutral
Oxbridge Re	Neutral

43.0% of Hippo shares are owned by institutional investors. Comparatively, 5.6% of Oxbridge Re shares are owned by institutional investors. 10.8% of Hippo shares are owned by insiders. Comparatively, 16.3% of Oxbridge Re shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Hippo has higher revenue and earnings than Oxbridge Re. Oxbridge Re is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hippo	$468.60M	0.06	$57.70M	$4.32	6.06
Oxbridge Re	$2.58M	3.23	-$2.08M	-$0.25	N/A

Hippo has a beta of 1.53, suggesting that its stock price is 53% more volatile than the broader market. Comparatively, Oxbridge Re has a beta of 2.05, suggesting that its stock price is 105% more volatile than the broader market.

Hippo has a net margin of 23.45% compared to Oxbridge Re's net margin of -76.47%. Hippo's return on equity of 12.17% beat Oxbridge Re's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hippo	23.45%	12.17%	2.64%
Oxbridge Re	-76.47%	-33.33%	-22.04%

Summary

Hippo beats Oxbridge Re on 13 of the 16 factors compared between the two stocks.

How does Oxbridge Re compare to Zhibao Technology?

Zhibao Technology (NASDAQ:ZBAO) and Oxbridge Re (NASDAQ:OXBR) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

Zhibao Technology has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market. Comparatively, Oxbridge Re has a beta of 2.05, indicating that its stock price is 105% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhibao Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Zhibao Technology has a net margin of 0.00% compared to Oxbridge Re's net margin of -76.47%. Zhibao Technology's return on equity of 0.00% beat Oxbridge Re's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zhibao Technology	N/A	N/A	N/A
Oxbridge Re	-76.47%	-33.33%	-22.04%

5.6% of Oxbridge Re shares are held by institutional investors. 16.3% of Oxbridge Re shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Zhibao Technology's average media sentiment score of 0.00 equaled Oxbridge Re'saverage media sentiment score.

Company	Overall Sentiment
Zhibao Technology	Neutral
Oxbridge Re	Neutral

Oxbridge Re has lower revenue, but higher earnings than Zhibao Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhibao Technology	$38.66M	0.85	-$8.66M	N/A	N/A
Oxbridge Re	$2.58M	3.23	-$2.08M	-$0.25	N/A

Summary

Oxbridge Re beats Zhibao Technology on 5 of the 9 factors compared between the two stocks.

How does Oxbridge Re compare to Presurance?

Oxbridge Re (NASDAQ:OXBR) and Presurance (NASDAQ:PRHI) are both small-cap insurance companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Oxbridge Re has higher earnings, but lower revenue than Presurance. Oxbridge Re is trading at a lower price-to-earnings ratio than Presurance, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oxbridge Re	$2.58M	3.23	-$2.08M	-$0.25	N/A
Presurance	$43.30M	0.44	-$18.44M	-$1.39	N/A

Presurance has a net margin of -41.92% compared to Oxbridge Re's net margin of -76.47%. Oxbridge Re's return on equity of -33.33% beat Presurance's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oxbridge Re	-76.47%	-33.33%	-22.04%
Presurance	-41.92%	-104.13%	-8.74%

Oxbridge Re has a beta of 2.05, indicating that its stock price is 105% more volatile than the broader market. Comparatively, Presurance has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Presurance	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Presurance had 2 more articles in the media than Oxbridge Re. MarketBeat recorded 2 mentions for Presurance and 0 mentions for Oxbridge Re. Oxbridge Re's average media sentiment score of 0.00 equaled Presurance'saverage media sentiment score.

Company	Overall Sentiment
Oxbridge Re	Neutral
Presurance	Neutral

5.6% of Oxbridge Re shares are owned by institutional investors. Comparatively, 34.9% of Presurance shares are owned by institutional investors. 16.3% of Oxbridge Re shares are owned by company insiders. Comparatively, 73.3% of Presurance shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Presurance beats Oxbridge Re on 7 of the 12 factors compared between the two stocks.

How does Oxbridge Re compare to Huize?

Huize (NASDAQ:HUIZ) and Oxbridge Re (NASDAQ:OXBR) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

In the previous week, Huize had 1 more articles in the media than Oxbridge Re. MarketBeat recorded 1 mentions for Huize and 0 mentions for Oxbridge Re. Huize's average media sentiment score of 0.00 equaled Oxbridge Re'saverage media sentiment score.

Company	Overall Sentiment
Huize	Neutral
Oxbridge Re	Neutral

Huize has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Oxbridge Re has a beta of 2.05, suggesting that its share price is 105% more volatile than the broader market.

Huize presently has a consensus target price of $2.30, suggesting a potential upside of 31.43%. Given Huize's stronger consensus rating and higher possible upside, equities research analysts plainly believe Huize is more favorable than Oxbridge Re.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Huize	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Huize has higher revenue and earnings than Oxbridge Re. Oxbridge Re is trading at a lower price-to-earnings ratio than Huize, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Huize	$226.26M	0.08	$580K	$0.03	58.33
Oxbridge Re	$2.58M	3.23	-$2.08M	-$0.25	N/A

5.6% of Oxbridge Re shares are held by institutional investors. 30.4% of Huize shares are held by company insiders. Comparatively, 16.3% of Oxbridge Re shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Huize has a net margin of 0.00% compared to Oxbridge Re's net margin of -76.47%. Huize's return on equity of 0.00% beat Oxbridge Re's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Huize	N/A	N/A	N/A
Oxbridge Re	-76.47%	-33.33%	-22.04%

Summary

Huize beats Oxbridge Re on 11 of the 14 factors compared between the two stocks.

How does Oxbridge Re compare to GoHealth?

GoHealth (NASDAQ:GOCO) and Oxbridge Re (NASDAQ:OXBR) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Oxbridge Re has a net margin of -76.47% compared to GoHealth's net margin of -189.73%. Oxbridge Re's return on equity of -33.33% beat GoHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoHealth	-189.73%	-541.82%	-10.62%
Oxbridge Re	-76.47%	-33.33%	-22.04%

24.2% of GoHealth shares are held by institutional investors. Comparatively, 5.6% of Oxbridge Re shares are held by institutional investors. 34.0% of GoHealth shares are held by insiders. Comparatively, 16.3% of Oxbridge Re shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

GoHealth presently has a consensus price target of $5.00, suggesting a potential upside of 663.83%. Given GoHealth's stronger consensus rating and higher possible upside, research analysts clearly believe GoHealth is more favorable than Oxbridge Re.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoHealth	1 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.20
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, GoHealth's average media sentiment score of 3.00 beat Oxbridge Re's score of 0.00 indicating that GoHealth is being referred to more favorably in the media.

Company	Overall Sentiment
GoHealth	Very Positive
Oxbridge Re	Neutral

GoHealth has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market. Comparatively, Oxbridge Re has a beta of 2.05, meaning that its stock price is 105% more volatile than the broader market.

Oxbridge Re has lower revenue, but higher earnings than GoHealth. Oxbridge Re is trading at a lower price-to-earnings ratio than GoHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoHealth	$361.85M	0.05	-$257.13M	-$18.45	N/A
Oxbridge Re	$2.58M	3.23	-$2.08M	-$0.25	N/A

Summary

GoHealth beats Oxbridge Re on 9 of the 15 factors compared between the two stocks.

Get Oxbridge Re News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OXBR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OXBR vs. The Competition

Export

Metric	Oxbridge Re	INS Industry	Finance Sector	NASDAQ Exchange
Market Cap	$8.34M	$20.12B	$13.61B	$12.34B
Dividend Yield	N/A	1.83%	5.82%	5.28%
P/E Ratio	-4.12	20.34	23.98	25.65
Price / Sales	3.23	97.57	153.62	86.31
Price / Cash	N/A	11.24	20.15	56.67
Price / Book	1.37	2.74	2.15	7.14
Net Income	-$2.08M	$1.06B	$1.13B	$335.98M
7 Day Performance	7.68%	0.44%	1.05%	4.15%
1 Month Performance	31.04%	1.48%	-0.08%	2.54%
1 Year Performance	-42.30%	-22.04%	12.11%	35.06%

Oxbridge Re Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OXBR Oxbridge Re	0.1064 of 5 stars	$1.03 flat	N/A	-42.3%	$8.34M	$2.58M	N/A	3	Gap Up
HIPO Hippo	4.5529 of 5 stars	$25.97 +0.6%	$38.33 +47.6%	+16.9%	$27.01M	$468.60M	6.01	620
ZBAO Zhibao Technology	0.2156 of 5 stars	$0.81 -6.9%	N/A	-2.9%	$26.50M	$38.66M	N/A	148	Gap Down
PRHI Presurance	1.2631 of 5 stars	$0.77 +18.8%	N/A	N/A	$20.06M	$43.30M	N/A	150	News Coverage
HUIZ Huize	2.5529 of 5 stars	$1.80 +1.7%	$2.30 +27.8%	-15.9%	$18.16M	$1.58B	60.00	1,640	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OXBR) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oxbridge Re (OXBR) Competitors

OXBR vs. HIPO, ZBAO, PRHI, HUIZ, and GOCO

How does Oxbridge Re compare to Hippo?

Summary

How does Oxbridge Re compare to Zhibao Technology?

Summary

How does Oxbridge Re compare to Presurance?

Summary

How does Oxbridge Re compare to Huize?

Summary

How does Oxbridge Re compare to GoHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OXBR vs. The Competition

Oxbridge Re Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oxbridge Re (OXBR) Competitors

OXBR vs. HIPO, ZBAO, PRHI, HUIZ, and GOCO

How does Oxbridge Re compare to Hippo?

Do analysts prefer HIPO or OXBR?

Does the media prefer HIPO or OXBR?

Do institutionals and insiders believe in HIPO or OXBR?

Which has better earnings & valuation, HIPO or OXBR?

Which has more volatility and risk, HIPO or OXBR?

Is HIPO or OXBR more profitable?

Summary

How does Oxbridge Re compare to Zhibao Technology?

Which has more risk and volatility, ZBAO or OXBR?

Do analysts rate ZBAO or OXBR?

Is ZBAO or OXBR more profitable?

Do insiders and institutionals believe in ZBAO or OXBR?

Does the media favor ZBAO or OXBR?

Which has preferable valuation and earnings, ZBAO or OXBR?

Summary

How does Oxbridge Re compare to Presurance?

Which has better valuation and earnings, OXBR or PRHI?

Is OXBR or PRHI more profitable?

Which has more volatility & risk, OXBR or PRHI?

Do analysts prefer OXBR or PRHI?

Does the media refer more to OXBR or PRHI?

Do institutionals & insiders have more ownership in OXBR or PRHI?

Summary

How does Oxbridge Re compare to Huize?

Does the media favor HUIZ or OXBR?

Which has more risk and volatility, HUIZ or OXBR?

Do analysts prefer HUIZ or OXBR?

Which has stronger valuation & earnings, HUIZ or OXBR?

Do insiders & institutionals have more ownership in HUIZ or OXBR?

Is HUIZ or OXBR more profitable?

Summary

How does Oxbridge Re compare to GoHealth?

Is GOCO or OXBR more profitable?

Do insiders and institutionals have more ownership in GOCO or OXBR?

Do analysts prefer GOCO or OXBR?

Does the media favor GOCO or OXBR?

Which has more risk & volatility, GOCO or OXBR?

Which has better earnings and valuation, GOCO or OXBR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OXBR vs. The Competition

Oxbridge Re Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools